ATR
AptarGroup, Inc.
NYSE Healthcare United States
124,63 $US
+0.10% today
+1.71% YTD · -4.13% 1Y
4
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
16
Hedge funds tracked
Latest available SEC 13F filings
72
/ 100
STRONG

Analysis AptarGroup, Inc. (ATR) — Kairos Score 72/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Key info

👔
CEO
Mr. Gael Touya
📍
HQ
265 Exchange Drive, Suite 301, Crystal Lake, IL, 60014, United States
👥
Employees
14 000
💰
Market cap
7 924 115 968,00 $US
📊
P/E
22.5
💸
Dividend yield
1.54%

🕴️ Insider activity (90 days)

4 transactions — 0 buys and 3 sales reported by AptarGroup, Inc. executives.

VS
Vinczeller Shiela
Chief Human Resources Officer · 2026-09-02
Sell
TG
Touya Gael
President and CEO · 2026-09-01
Other
TG
Touya Gael
Segment Pres., CEO Designate · 2026-08-27
Sell

🏦 Hedge Funds

16 institutional funds report a position on ATR in their latest SEC quarterly filing.

VANGUARD GROUP INC
BlackRock, Inc.
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO
VANGUARD PORTFOLIO MANAGEMENT LLC
MORGAN STANLEY

📰 Recent news

15 recent articles on ATR.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as AptarGroup, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of ATR on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 4 insider transactions over 90 days
✅ All 16 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year